Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013 (2013), Article ID 426207, 12 pages
http://dx.doi.org/10.1155/2013/426207
Review Article

Does the Couse of Astragalus-Containing Chinese Herbal Prescriptions and Radiotherapy Benefit to Non-Small-Cell Lung Cancer Treatment: A Meta-Analysis of Randomized Trials

Department of Respiratory Medicine, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, 155 Hanzhong Road, Nanjing 210029, China

Received 20 August 2013; Accepted 10 November 2013

Academic Editor: C. S. Cho

Copyright © 2013 Hailang He et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Siegel, D. Naishadham, and A. Jemal, “Cancer statistics, 2013,” A Cancer Journal for Clinicians, vol. 63, no. 1, pp. 11–30, 2013. View at Publisher · View at Google Scholar
  2. R. L. Keith and Y. E. Miller, “Lung cancer chemoprevention: current status and future prospects,” Nature Reviews, vol. 10, no. 6, pp. 334–343, 2013. View at Publisher · View at Google Scholar
  3. J. She, P. Yang, Q. Y. Hong, and C. X. Bai, “Lung cancer in China: challenges and interventions,” Chest, vol. 143, no. 4, pp. 1117–1126, 2013. View at Google Scholar
  4. Y. Yang, H. Li, S. C. Hou, B. Hu, J. Liu, and J. Wang, “The noncoding RNA expression profile and the effect of lncRNA AK126698 on cisplatin resistance in Non-Small-Cell Lung Cancer Cell,” PLoS ONE, vol. 8, no. 5, Article ID e65309, 2013. View at Google Scholar
  5. J. P. C. Grutters, A. G. H. Kessels, M. Pijls-Johannesma, D. de Ruysscher, M. A. Joore, and P. Lambin, “Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: a meta-analysis,” Radiotherapy and Oncology, vol. 95, no. 1, pp. 32–40, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Ishikura, “Optimal radiotherapy for non-small-cell lung cancer: current progress and future challenges,” General Thoracic and Cardiovascular Surgery, vol. 60, no. 3, pp. 127–131, 2012. View at Google Scholar
  7. S. G. Li, H. Y. Chen, C. S. Ou-Yang et al., “The efficacy of Chinese herbal medicine as an adjunctive therapy for advanced non-small cell lung cancer: a systematic review and meta-analysis,” PLoS ONE, vol. 8, no. 2, Article ID e57604, 2013. View at Google Scholar
  8. L. L. Jia, S. M. Ma, X. Hou et al., “The synergistic effects of traditional Chinese herbs and radiotherapy for cancer treatment,” Oncology Letters, vol. 5, no. 5, pp. 1439–1447, 2013. View at Google Scholar
  9. T.-K. Lee, R. M. Johnke, R. R. Allison, K. F. O'Brien, and L. J. Dobbs Jr., “Radioprotective potential of ginseng,” Mutagenesis, vol. 20, no. 4, pp. 237–243, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. National Pharmacopoeia Committee, Pharmacopoeia of People’s Republic of China, Part 1, Chemical Industry Press, Beijing, Chnia, 2010.
  11. M. M. Y. Tin, C.-H. Cho, K. Chan, A. E. James, and J. K. S. Ko, “Astragalus saponins induce growth inhibition and apoptosis in human colon cancer cells and tumor xenograft,” Carcinogenesis, vol. 28, no. 6, pp. 1347–1355, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. P. C. Law, K. K. Auyeung, L. Y. Chan, and J. K. Ko, “Astragalus saponins downregulate vascular endothelial growth factor under cobalt chloride-stimulated hypoxia in colon cancer cells,” BMC Complementary and Alternative Medicine, vol. 12, article 160, 12 pages, 2012. View at Publisher · View at Google Scholar
  13. W. C. S. Cho and K. N. Leung, “In vitro and in vivo anti-tumor effects of Astragalus membranaceus,” Cancer Letters, vol. 252, no. 1, pp. 43–54, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Frøkiær, L. Henningsen, S. B. Metzdorff et al., “Astragalus root and elderberry fruit extracts enhance the IFN-β stimulatory effects of Lactobacillus acidophilus in murine-derived dendritic cells,” PLoS ONE, vol. 7, no. 10, Article ID e47878, 2012. View at Google Scholar
  15. M. McCulloch, C. See, X.-J. Shu et al., “Astragalus-based Chinese herbs and platinum-based chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trials,” Journal of Clinical Oncology, vol. 24, no. 3, pp. 419–430, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Wu, Y. B. Chen, Y. J. Xu et al., “Oral huangqi formulae for stable chronic obstructive pulmonary disease: a systematic review and meta-analysis,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 705315, 14 pages, 2013. View at Publisher · View at Google Scholar
  17. J. P. T. Higgins and S. Green, “Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0,” The Cochrane Collaboration, 2011, http://www.cochrane.org/training/cochrane-handbook.
  18. The World Health Organization, WHO Handbook for Reporting Results of Cancer Treatment, World Health Orgnaization, Geneva, Switzerland, 1979.
  19. J. W. Yates, B. Chalmer, and F. P. McKegney, “Evaluation of patients with advanced cancer using the Karnofsky performance status,” Cancer, vol. 45, no. 8, pp. 2220–2224, 1980. View at Google Scholar · View at Scopus
  20. T. T. Song, Y. H. Jiang, and X. Z. Lan, “The observation of the rapeutic efficacy of Chinese medicine combined with radiotherapy in treatment of elderly patients with NSCLC,” Journal of Practical Oncology, vol. 21, no. 2, pp. 135–136, 2007 (Chinese). View at Google Scholar
  21. Z. G. Huang and Y. Hou, “An evaluation of the efficacy of AD Injection in combination with three-dimensional conformal radiotherapy for elderly patients with non-small-cell-lung carcinoma,” Journal of YouJiang Medical College for Nationalities, vol. 30, no. 5, pp. 724–725, 2008 (Chinese). View at Google Scholar
  22. H. Qin, D. Niu, C. Jiang et al., “Effect of astragalus polysaccharide in combination with three-dimensional conformal radiotherapy on elderly patients with non-small cell lung cancer,” Chinese Journal of Clinical Oncology, vol. 36, no. 24, pp. 1401–1403, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. W. Gao, L. J. Yin, T. G. Ding, J. Wang, and W. Chen, “Shenqi ten blindly particles combined with radiotherapy for elderly patients with non-small cell lung cancer,” Chinese Journal of Clinical Oncology and Rehabilitation, vol. 19, no. 5, pp. 397–399, 2012 (Chinese). View at Google Scholar
  24. K. Cai, J. B. Liu, C. J. Huang, Z. S. Yu, T. H. Liao, and L. L. Huang, “Effects of YiQi YangYin drugs on life quality and immunologic function in senile patients with local advanced non-small-cell lung cancer undergoing three dimensional conformal radiotherapy,” Western Journal of Traditional Chinese Medicine, vol. 25, no. 11, pp. 1–4, 2012 (Chinese). View at Google Scholar
  25. J. Wu, “Observation of effects of Aidi Injection in the radiotherapy of non-small cell lung cancer,” China Journal of Cancer Prevention and Treatment, vol. 10, no. 4, pp. 403–404, 2003 (Chinese). View at Google Scholar
  26. X. X. Wen, “Clinical observation of the effects of radiotherapy in combination with Aidi Injection in treatment of elderly patients with non-small cell lung cancer,” Chinese Journal of Hospital Pharmacy, vol. 25, no. 9, pp. 851–852, 2005 (Chinese). View at Google Scholar
  27. Y. S. Jia, B. H. Lin, and S. Q. Wu, “Clinical research on Aidi Injection combined with radiotherapy for non-small-cell lung cancer,” Chinese Archives of Traditional Chinese Medicine, vol. 28, no. 7, pp. 1556–1558, 2010 (Chinese). View at Google Scholar
  28. Z. Yang, “Clinical study on AiDi Injection combined with radiotherapy for 46 cases of non-small cell lung cancer,” China Health Industry, vol. 10, no. 5, p. 81, 2013 (Chinese). View at Google Scholar
  29. J. Huang, P. W. Li, and L. Q. Jia, “Complementary effect of Fuzheng Zengxiao Fomular combining with radiotherapy in non-small cell lung cancer,” Journal of China-Japan Friendship Hospital, vol. 19, no. 5, pp. 278–280, 2005 (Chinese). View at Google Scholar
  30. H.-B. Cai, F.-G. Dai, Q.-F. Min, M. Shi, J.-X. Miao, and R.-C. Luo, “Clinical study of the effects of radiotherapy in combination with traditional Chinese medicine on non-small cell lung cancer,” Journal of First Military Medical University, vol. 22, no. 12, pp. 1112–1115, 2002 (Chinese). View at Google Scholar · View at Scopus
  31. H. J. Wang, Z. X. Wang, and J. F. Guo, “The clinical study on Jiawei Baihe Gujin decoction combined with radiotherapy in the treatment of stage III non-small cell lung cancer,” Chinese Archives of Traditional Chinese Medicine, vol. 24, no. 10, pp. 1920–1921, 2006 (Chinese). View at Google Scholar
  32. G. M. Zhang, B. R. Xiao, R. K. Mao, H. L. Long, and X. M. Zhao, “Study on NSCLC treated with Chinese medicine combined with three-dimensional conformal radiotherapy,” Chinese Journal of Clinical Oncology and Rehabilitation, vol. 13, no. 4, pp. 325–328, 2006 (Chinese). View at Google Scholar
  33. G. Y. Zhao, W. Dong, J. J. Feng et al., “The observation of the rapeutic efficacy of Chinesse medicine combined with radiotherapy in treatment of elderly patients with stage IIIa/IIIb non-small cell lung cancer,” Cancer Research and Clinic, vol. 23, no. 4, pp. 274–276, 2011 (Chinese). View at Google Scholar
  34. Z. Y. Li, S. Q. Nin, T. N. Yi, and G. Q. Liu, “The observation of the action-enhancing and toxicity-reducing efficacy of AiDi Injection combined with radiotherapy in treating lung cancer,” Journal of Clinical Pulmonary Medicine, vol. 18, no. 2, pp. 367–368, 2013 (Chinese). View at Google Scholar
  35. X. Z. Lan and Y. H. Jiang, “Observation on therapeutic effects of 26 cases of senile late non-small cell pulmonary carcinoma treated with radiotherapy combined with chinese drugs,” Journal of Traditional Chinese Medicine, vol. 43, no. 2, pp. 125–126, 2002 (Chinese). View at Google Scholar
  36. F. Chen and X. L. Wang, “The observation of the action-enhancing and toxicity-reducing efficacy of KangAi Injection combined with radiotherapy in treating Stage III/IV non-small cell lung cancer,” China Journal of Chinese Materia Medica, vol. 31, no. 18, pp. 1553–1554, 2006 (Chinese). View at Google Scholar
  37. J. Q. Ma, “The observation of the synergism effects of KangAi Injection combined with radiotherapy in treating advanved non-small-cell lung cancer,” China Journal of Chinese Materia Medica, vol. 31, no. 18, pp. 1556–1558, 2006 (Chinese). View at Google Scholar
  38. Y. P. Tian and Q. C. Wang, “The observation of the rapeutic efficacy of AiDi Injection combined with radiotherapy in treatment of elderly patients with advanced NSCLC,” Pharmacology and Clinics of Chinese Materia Medica, vol. 23, no. 4, pp. 57–58, 2007 (Chinese). View at Google Scholar
  39. T. J. Wang, Y. Jiang, H. Y. Wang, and Z. F. Zhao, “The observation of the rapeutic efficacy of Shenqifuzheng Injection combined with radiotherapy in treating limited and advanced non-small cell lung cancer,” Modern Oncology, vol. 15, no. 11, pp. 1672–1674, 2007 (Chinese). View at Google Scholar
  40. M. Jiang and J. H. Xu, “The clinical study on Delisheng (DLS) combined with radiotherapy in the treatment of advanced non small cell lung cancer (NSCLC),” Guide of China Medicine, vol. 6, no. 17, pp. 29–30, 2008 (Chinese). View at Google Scholar
  41. Y. S. Xie, Q. Zhang, and R. Wang, “Shenqifuzheng Injection combined with 3-dimensional conformal radiotherapy for 46 cases of advanced non-small cell lung cancer,” Herald of Medicine, vol. 28, no. 10, pp. 1290–1292, 2009 (Chinese). View at Google Scholar
  42. Y. Liu, H. P. Jiang, Y. L. Wang et al., “The clinical study of treating advanced non-small cell lung cancer combining radiotherapy with Taile oral liquid,” Journal of Bethune Military Medical College, vol. 7, no. 3, pp. 136–137, 2009 (Chinese). View at Google Scholar
  43. Y. X. Wang, S. M. Zheng, H. M. Fan, R. He, J. Li, and X. R. Xiao, “Shenqi Fuzheng Injection combined with three dimensional conformal radiotherapy for old patient's advanced non-small cell lung cancer,” Chongqing Medicine, vol. 38, no. 4, pp. 460–461, 2009 (Chinese). View at Google Scholar
  44. Y. H. Ji, J. L. Zhang, M. X. Ni, J. Cai, and J. B. Liu, “Effects of Bukangling on the radiotherapy for advanced non-small-cell lung cancer,” Journal of Chinese Practical Diagnosis and Therapy, vol. 25, no. 12, pp. 1163–1165, 2011 (Chinese). View at Google Scholar
  45. Y. Mu, Y. M. Ruan, and J. Zhou, “Clinical study on Shenqifuzheng Injection combined with radiotherapy for 35 cases of advanced non-small cell lung cancer,” Guiding Journal of Traditional Chinese Medicine and Pharmacy, vol. 18, no. 10, pp. 39–41, 2012 (Chinese). View at Google Scholar
  46. H. Y. Wang, X. J. Jia, Y. B. Chen, and T. J. Wang, “The observation of the rapeutic efficacy of KangAi Injection combined with three dimensional conformal radiotherapy in treating locally anvanced non-small cell lung cancer,” Chinese Journal of Gerontology, vol. 32, no. 17, pp. 3788–3789, 2012 (Chinese). View at Google Scholar
  47. Y. F. Nin, L. Z. Yang, B. L. Yang, and Y. H. Li, “Effects of Jiawei Shiquan Fomular on immunologic function in patients with non-small-cell lung cancer undergoing radiotherapy,” Chinese Journal of Coal Industry Medicine, vol. 5, no. 2, p. 155, 2002 (Chinese). View at Google Scholar
  48. T. X. Fu, Q. Tang, and B. Nie, “Clinical observation of Zhenqi Fuzheng capsules combined by radiotherapy in treatment of elderly patients with advanced NSCLC,” Chinese Journal of Pharmacoepidemiology, vol. 17, no. 1, pp. 4–6, 2008 (Chinese). View at Google Scholar
  49. S. R. Heritier, V. J. Gebski, and A. C. Keech, “Inclusion of patients in clinical trial analysis: the intention-to-treat principle,” Medical Journal of Australia, vol. 179, no. 8, pp. 438–440, 2003. View at Google Scholar · View at Scopus
  50. C. Hewitt, S. Hahn, D. J. Torgerson, J. Watson, and J. M. Bland, “Adequacy and reporting of allocation concealment: review of recent trials published in four general medical journals,” British Medical Journal, vol. 330, no. 7499, pp. 1057–1058, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. E. Ernst and M. Lee, “A trial design that generates only “positive” results,” Journal of Postgraduate Medicine, vol. 54, no. 3, pp. 214–216, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. K. I. Block and M. N. Mead, “Immune system effects of Echinacea, Ginseng, and Astragalus: a review,” Integrative Cancer Therapies, vol. 2, no. 3, pp. 247–267, 2003. View at Publisher · View at Google Scholar · View at Scopus
  53. C. Chu, L.-W. Qi, E.-H. Liu, B. Li, W. Gao, and P. Li, “Radix astragali (Astragalus): latest advancements and trends in chemistry, analysis, pharmacology and pharmacokinetics,” Current Organic Chemistry, vol. 14, no. 16, pp. 1792–1807, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. L. Guo, S.-P. Bai, L. Zhao, and X.-H. Wang, “Astragalus polysaccharide injection integrated with vinorelbine and cisplatin for patients with advanced non-small cell lung cancer: effects on quality of life and survival,” Medical Oncology, vol. 29, no. 3, pp. 1656–1662, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. Z.-Y. Zhuge, Y.-H. Zhu, P.-Q. Liu et al., “Effects of astragalus polysaccharide on immune responses of porcine PBMC stimulated with PRRSV or CSFV,” PLoS ONE, vol. 7, no. 1, Article ID e29320, 2012. View at Publisher · View at Google Scholar · View at Scopus
  56. X. G. Du, B. Zhao, J. Y. Li et al., “Astragalus polysaccharides enhance immune responses of HBV DNA vaccination via promoting the dendritic cell maturation and suppressing Treg frequency in mice,” International Immunopharmacology, vol. 14, no. 4, pp. 463–470, 2012. View at Google Scholar
  57. L. W. Guo, J. G. Liu, Y. L. Hu et al., “Astragalus polysaccharide and sulfated epimedium polysaccharide synergistically resist the immunosuppression,” Carbohydrate Polymers, vol. 90, no. 2, pp. 1055–1060, 2012. View at Google Scholar
  58. K. F. Schulz, D. G. Altman, and D. Moher, “CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials,” Journal of Clinical Epidemiology, vol. 63, no. 8, pp. 834–840, 2010. View at Publisher · View at Google Scholar · View at Scopus